Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
Testing the Efficacy of Viome Precision Supplements to Improve Clinical Outcomes for Mental Health Conditions
1 other identifier
interventional
60
1 country
1
Brief Summary
US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of two arms. This study is direct to participant and will not utilize clinical sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2023
CompletedFirst Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 5, 2024
January 1, 2024
1 year
December 8, 2023
January 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in PHQ-9 Score
Change in PHQ-9 score for VPNP group compared to baseline scores.
4 months
Change in GAD-7 Score
Change in GAD-7 score for VPNP group compared to baseline scores.
4 months
Change in Quality of Life Score
Change in quality of life score for VPNP group compared to baseline scores.
4 months
Change in Perceived Stress Scale Score
Change in perceived stress score for VPNP group compared to baseline scores.
4 months
Study Arms (2)
Placebo
PLACEBO COMPARATORParticipants who have mental health issues are randomized into this study arm. They may be provided with any combination of nutritional recommendations and supplements. Placebo capsules will contain inert and inactive materials. Participants may need to use a mobile app in order to participate in the trial.
Viome's Precision Nutrition Program (VPNP)
EXPERIMENTALParticipants who have mental health issues are randomized into this study arm. They may be provided with any combination of nutritional recommendations and supplements. Participants may need to use a mobile app in order to participate in the trial.
Interventions
Precision supplement based on the participants microbiome sample results. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching.
Participants who have mental health issues are randomized into this arm. They may be provided with any combination of nutritional recommendations and/or supplements. Placebo capsules will contain inert and inactive materials. Participants may need to use a mobile app in order to participate in the trial.
Eligibility Criteria
You may qualify if:
- Resident of the United States
- years old and older OR BMI of 25 or greater
- Able to speak and read English
- No unexplained weight loss, fevers, anemia, or blood in stool
- Willing and able to follow the trial instructions, as described in the recruitment letter
- Signed and dated informed consent prior to any trial-specific procedures.
- PHQ9 score of 5-24 (inclusive)
You may not qualify if:
- Unwilling to change their current diet
- Prior use of Viome products or services
- Antibiotic use in the previous 4 weeks
- Pregnancy (current or planned in the next 4 months)
- \< 90 days postpartum
- Breast feeding
- Active infection
- Unable or unwilling to use Viome's App on an iPhone or Android smartphone
- Significant diet or lifestyle change in the previous 1 month
- IBD diagnosis -Major psychiatric/DSM-4 disease diagnosis (e.g. Schizophrenia, Bipolar disorder, Post- traumatic Stress Disorder, Obsessive Compulsive disorder)
- Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial
- Cancer therapy within the previous 1 year
- Major surgery in the last 6 months or planned in the next 4 months
- Allergies to any supplement ingredients listed in the screening survey
- Currently on a specific diet: FODMAP, KETO, PALEO
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Viomelead
Study Sites (1)
Viome Life Sciences
Bothell, Washington, 98011, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Momchilo Vuyisich
Viome
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Once enrolled, participants are randomized into one of the 2 study arms. The coded supplements with blinded labels are shipped to the participants. The participants are not aware of which group they are randomized into.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2023
First Posted
January 5, 2024
Study Start
October 26, 2023
Primary Completion
October 31, 2024
Study Completion
December 31, 2024
Last Updated
January 5, 2024
Record last verified: 2024-01